2-[4-[[(3R)-3-[[3-(trifluoromethoxy)phenyl]sulfonylmethyl]pyrrolidin-1-yl]methyl]phenyl]-1,3-thiazole
C22H21F3N2O3S2 — CID 157065958
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[[(3R)-3-[[3-(trifluoromethoxy)phenyl]sulfonylmethyl]pyrrolidin-1-yl]methyl]phenyl]-1,3-thiazole
2-[4-[[(3R)-3-[[3-(trifluoromethoxy)phenyl]sulfonylmethyl]pyrrolidin-1-yl]methyl]phenyl]-1,3-thiazole (PubChem CID 157065958) has the molecular formula C22H21F3N2O3S2 and a molecular weight of 482.55 g/mol. Its IUPAC name is 2-[4-[[(3R)-3-[[3-(trifluoromethoxy)phenyl]sulfonylmethyl]pyrrolidin-1-yl]methyl]phenyl]-1,3-thiazole.
Molecular Properties
| Compound Name | 2-[4-[[(3R)-3-[[3-(trifluoromethoxy)phenyl]sulfonylmethyl]pyrrolidin-1-yl]methyl]phenyl]-1,3-thiazole |
|---|---|
| PubChem CID | 157065958 |
| Molecular Formula | C22H21F3N2O3S2 |
| Molecular Weight | 482.55 g/mol |
| Exact Mass | 482.09 |
| IUPAC Name | 2-[4-[[(3R)-3-[[3-(trifluoromethoxy)phenyl]sulfonylmethyl]pyrrolidin-1-yl]methyl]phenyl]-1,3-thiazole |
| SMILES | O=S(=O)(C[C@@H]1CCN(Cc2ccc(-c3nccs3)cc2)C1)c1cccc(OC(F)(F)F)c1 |
| InChI | InChI=1S/C22H21F3N2O3S2/c23-22(24,25)30-19-2-1-3-20(12-19)32(28,29)15-17-8-10-27(14-17)13-16-4-6-18(7-5-16)21-26-9-11-31-21/h1-7,9,11-12,17H,8,10,13-15H2/t17-/m1/s1 |
| InChIKey | ABWLGECIJIOPAG-QGZVFWFLSA-N |
| XLogP | 5.00 |
| TPSA | 59.50 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 482.55 |
| LogP ≤ 5 | 5.00 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157065958 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.